Prepare thoroughly for the Genitourinary System Disorders Test. Explore flashcards and multiple choice questions with explanations. Enhance your readiness for the examination!

Multiple Choice

Why are patients with diabetes at high risk of nephropathy and what are early screening measures?

Chronic high blood glucose from diabetes damages the kidney’s tiny filtering units, the glomeruli. This injury leads to changes like glomerulosclerosis and thickening of the glomerular basement membrane, which makes the kidneys leak small amounts of albumin into the urine long before overall kidney function noticeably declines. That early leak—microalbuminuria—is the earliest warning sign of diabetic nephropathy and is why screening focuses on detecting it and on assessing kidney function overall. So the best approach is to screen annually for microalbuminuria using a urine albumin-to-creatinine ratio (or a similar microalbumin test) and to estimate the glomerular filtration rate (GFR) to monitor kidney function. This combination catches nephropathy early and guides timely interventions to slow progression. Other options don’t fit the situation: hypoglycemia isn’t the primary driver of nephropathy, screening only for blood glucose misses kidney-specific signs, relying only on creatinine without looking for albumin loss misses early disease, and the idea that diabetes protects the kidneys is incorrect.

Chronic high blood glucose from diabetes damages the kidney’s tiny filtering units, the glomeruli. This injury leads to changes like glomerulosclerosis and thickening of the glomerular basement membrane, which makes the kidneys leak small amounts of albumin into the urine long before overall kidney function noticeably declines. That early leak—microalbuminuria—is the earliest warning sign of diabetic nephropathy and is why screening focuses on detecting it and on assessing kidney function overall.

So the best approach is to screen annually for microalbuminuria using a urine albumin-to-creatinine ratio (or a similar microalbumin test) and to estimate the glomerular filtration rate (GFR) to monitor kidney function. This combination catches nephropathy early and guides timely interventions to slow progression.

Other options don’t fit the situation: hypoglycemia isn’t the primary driver of nephropathy, screening only for blood glucose misses kidney-specific signs, relying only on creatinine without looking for albumin loss misses early disease, and the idea that diabetes protects the kidneys is incorrect.